Charles Schwab’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Charles Schwab’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-82,642	Closed	-$1.3M	–	3552
2023 Q4	$1.3M	Buy	82,642 +10,783	+15%	+$104K	﹤0.01%	2756
2023 Q3	$557K	Hold	71,859	–	–	﹤0.01%	3008
2023 Q2	$714K	Buy	71,859 +13,126	+22%	+$105K	﹤0.01%	2892
2023 Q1	$341K	Hold	58,733	–	–	﹤0.01%	3057
2022 Q4	$466K	Buy	58,733 +9,894	+20%	+$42.5K	﹤0.01%	3023
2022 Q3	$155K	Sell	48,839 -4,633	-9%	-$29K	﹤0.01%	3191
2022 Q2	$307K	Sell	53,472 -5,080	-9%	-$39.6K	﹤0.01%	3186
2022 Q1	$413K	Buy	58,552 +24,820	+74%	+$390K	﹤0.01%	3136
2021 Q4	$772K	Buy	33,732 +975	+3%	+$25.2K	﹤0.01%	3011
2021 Q3	$970K	Buy	+32,757	New	+$1.11M	﹤0.01%	2886

Charles Schwab's ICVX Position: Q1 2024 in Review

Charles Schwab sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 82,642 shares — an estimated $1.3M sold.

Charles Schwab first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $1.3M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Charles Schwab reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Charles Schwab sold 82,642 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $1.3M.
Charles Schwab first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
Charles Schwab's Icosavax, Inc. Common Stock position peaked at $1.3M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.